The Potential Preventability of Postoperative Myocardial Infarction: Underuse of Perioperative β-Adrenergic Blockade

Archives of Internal Medicine

Volumn 164, Issue 7, 2004, Pages 762-766

  Lindenauer, Peter K ^a,b   Fitzgerald, Janice ^a   Hoople, Nancy ^a   Benjamin, Evan M ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; BETA ADRENERGIC RECEPTOR BLOCKING; COMMUNITY HOSPITAL; CONFIDENCE INTERVAL; FEMALE; HEART INFARCTION; HUMAN; MALE; MATHEMATICAL COMPUTING; MEDICAL RECORD; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REVIEW; TEACHING HOSPITAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 1842681497     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.7.762     Document Type: Review

References (31)

1. Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med. 1995;333:1750-1756.
2. Fleisher LA, Eagle KA. Clinical practice: lowering cardiac risk in noncardiac surgery. N Engl J Med. 2001;345:1677-1682.
3. Goldman L. Multifactorial index of cardiac risk in noncardiac surgery: ten-year status report. J Cardiothorac Anesth. 1987;1:237-244.
4. Lawrence VA, Hilsenbeck SG, Mulrow CD, Dhanda R, Sapp J, Page CP. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med. 1995;10:671-678.
5. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.
6. Collins TC, Daley J, Henderson WH, Khuri SF. Risk factors for prolonged length of stay after major elective surgery. Ann Surg. 1999;230:251-259.
7. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297:845-850.
8. Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med. 1986;1:211-219.
9. L'Italien GJ, Paul SD, Hendel RC, et al. Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1081 vascular surgical candidates. J Am Coll Cardiol. 1996;27:779-786.
10. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989;110:859-866.
11. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology. 1988;68:495-500.
12. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg. 1999; 88:477-482.
13. Mangano DT, Layug EL, Wallace A, Tateo I, Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery [published correction appears in N Engl J Med. 1997;336:1039]. N Engl J Med. 1996;335:1713-1720.
14. Mangano DT, Layug EL, Wallace A, Tateo I, Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery [published correction appears in N Engl J Med. 1997;336:1039]. N Engl J Med. 1996;335:1713-1720.
15. Poldermans D, Boersma E, Bax JJ, et al, Dutch Echocardiog raphic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789-1794.
16. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg. 2000;90:1257-1261.
17. Auerbach AD, Goldman L. β-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA. 2002;287:1435-1444.
18. Sonksen J, Gray R, Hutton P, Hickman PH. Safer non-cardiac surgery for patients with coronary artery disease: medical treatment should be optimised to improve outcome. BMJ. 1998;317:1400-1401.
19. Bodenheimer MM. Noncardiac surgery in the cardiac patient: what is the question? Ann Intern Med. 1996;124:763-766.
20. American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med. 1997;127:309-312.
21. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery-Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2002; 94:1052-1064.
22. Shojania KG, Duncan BW, McDonald KM, Wachter RM. Making Health Care Safer: A Critical Analysis of Patient Safety Practices: Evidence Report/Technology Assessment No. 43. Rockville, Md: Agency for Healthcare Research and Quality; 2001. Publication 01-E058.
23. Schmidt M, Lindenauer PK, Fitzgerald JL, Benjamin EM. Forecasting the clinical impact of a practice guideline for perioperative β-blockers to reduce cardiovascular morbidity and mortality. Arch Intern Med. 2002;162:63-69.
24. Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and β-blocker therapy. JAMA. 2001;285:1865-1873.
25. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
26. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest. 2001;120:1964-1971.
27. Lee JT. Wound infection surveillance. Infect Dis Clin North Am. 1992;6:643-656.
28. Surgical Infection Prevention Collaborative. Available at: http://www.qualishealth .org/collabs/sip/pdfs/sipc_framework_032802a.pdf. Accessed November 8, 2002.
29. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351-1357.
30. Krumholz HM, Radford MJ, Wang Y, Chen J, Marciniak TA. Early beta-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med. 1999; 131:648-654.
31. Holmboe ES, Meehan TP, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Use of critical pathways to improve the care of patients with acute myocardial infarction. Am J Med. 1999;107:324-331.